Amylyx Pharmaceuticals: Expect to Begin the Phase 3 Program for Avexitide in PBH in 1Q 2025 >AMLX
Amylyx Pharmaceuticals: Expect to Begin the Phase 3 Program for Avexitide in PBH in 1Q 2025 >AMLX
Amylyx藥品：預計在2025年第1季度開始PBH的Avexitide第3期計劃。>AMLX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊